INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

被引:6
作者
Chen, Ronald C. [1 ]
Karrison, Theodore [2 ]
Lawton, Colleen Anne [3 ]
Hall, William Adrian [3 ,4 ]
Borno, Hala [5 ]
Rosu, Mihaela [6 ]
Jani, Ashesh B. [7 ]
Schuster, David M. [8 ]
Seider, Michael J. [9 ]
Efstathiou, Jason A. [10 ]
Posadas, Edwin Melencio [11 ]
Nguyen, Paul L. [12 ]
Feng, Felix Y. [13 ]
机构
[1] Univ Kansas, Kansas City, KS USA
[2] Univ Chicago, Med & Biol Sci, Chicago, IL 60637 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] NRG Oncol, Milwaukee, WI USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[8] Winship Canc Inst, Atlanta, GA USA
[9] Akron City Hosp, Akron, OH USA
[10] Massachusetts Gen Hosp, Boston, MA 02114 USA
[11] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
[12] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[13] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
D O I
10.1200/JCO.2021.39.6_suppl.TPS179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS179
引用
收藏
页数:3
相关论文
empty
未找到相关数据